Effects of animal-assisted therapy with camelids in adult subjects with mental illness

Not Applicable

Recruiting

• Conditions: F32.2; F41.1; Severe depressive episode without psychotic symptoms; Generalized anxiety disorder

• Registration Number: DRKS00024036
• Lead Sponsor: Psychiatrische Klinik Charité Berlin

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2021-02-22
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 155

Inclusion Criteria

Patients with a mental illness from the group of affective illnesses, anxiety disorders as well as psychotic illnesses and personality disorders.

Exclusion Criteria

Suicidality, acute danger to oneself or others, severe psychotic experiences or severe physical illness that contradicts participation in the intervention.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The primary endpoint should be the subjects' psychovegetative activation in the form of a measurement of the activity of the pituitary-hypothalamus-adrenal system (stress axis”) and the activation of the sympathetic nervous system. In particular, the parameters salivary cortisol and salivary amylase are to be measured and the heart rate variability will be examined. The measurements will be taken immediately before and after the intervention/control-condition.

Secondary Outcome Measures

Name	Time	Method
Subjectively perceived anxiety and stress symptoms before and after the intervention are to be measured using standardized questionnaires - the State-Trait-Anxiety-Depression-Inventory (Laux et al., 2016), the State-Trait-Anxiety-Inventory (Spielberger et al., 2001) and the Positive Mental Health Scale (Lukat et al ., 2016). The measurements will be taken immediately before and after the intervention/control-condition.